Image Trademark with Serial Number 88880733
Status: 688 - Notice Of Allowance - Issued
Serial Number
88880733
Status
688 - Notice Of Allowance - Issued
Status Date
2021-12-28
Filing Date
2020-04-21
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
090104, 260121, 261709, 261901 - Ribbons, bows. Circles that are totally or partially shaded. Curved line(s), band(s) or bar(s). Spheres.
Published for Opposition Date
2021-11-02
Attorney Name
Law Office Assigned Location Code
N70
Employee Name
RIOS, SASHA BOSHART
Statements
Indication of Colors claimed
The colors white, blue, and red are claimed as a feature of the mark.
Description of Mark
The mark consists of a hollow sphere design outlined by brush-strokes resembling blue, red, and white ribbons. The upper left part of the sphere has a blue stripe going to the bottom left, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stripe. There is also a thin red stripe across the center of the sphere from the top to the bottom, and a white streak from the top right to the bottom left of the sphere. The light blue ribbon does not touch the dark blue ribbon. The background on which the design is placed and the center of the sphere represents transparent area.
Goods and Services
Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical preparations containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction,spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD)
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-04-30
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Danielle I. Mattessich
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2020-04-14 | 2020-041549 | Japan | True |
| False |
Trademark Events
| Event Date | Event Description |
| 2020-04-24 | NEW APPLICATION ENTERED IN TRAM |
| 2020-04-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-05-01 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2020-07-14 | ASSIGNED TO EXAMINER |
| 2020-07-15 | NON-FINAL ACTION WRITTEN |
| 2020-07-15 | NON-FINAL ACTION E-MAILED |
| 2020-07-15 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-01-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-01-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-01-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-01-28 | SUSPENSION LETTER WRITTEN |
| 2021-01-28 | LETTER OF SUSPENSION E-MAILED |
| 2021-01-28 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2021-06-15 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2021-07-15 | ASSIGNED TO LIE |
| 2021-07-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-07-19 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-08-23 | FINAL REFUSAL WRITTEN |
| 2021-08-23 | FINAL REFUSAL E-MAILED |
| 2021-08-23 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2021-08-31 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2021-08-31 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-08-31 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-09-20 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-09-20 | EXAMINERS AMENDMENT E-MAILED |
| 2021-09-20 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-09-20 | EXAMINER'S AMENDMENT ENTERED |
| 2021-09-20 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-09-24 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 2021-09-28 | ELECTRONIC RECORD REVIEW COMPLETE |
| 2021-10-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-11-02 | PUBLISHED FOR OPPOSITION |
| 2021-11-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-12-28 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
